At the dawn of the new millennium, Ting Han, a graduate of Tsinghua University in Beijing, followed his dream of going to the United States to pursue a career in biology. He enrolled at the University of Michigan, and in 2013, earned his Ph.D.
It was an important step for Han, who envisioned a career — and a life — here.
Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!
GET STARTEDWhat is it?
STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.
What's included?
- Daily reporting and analysis
- The most comprehensive industry coverage from a powerhouse team of reporters
- Subscriber-only newsletters
- Daily newsletters to brief you on the most important industry news of the day
- STAT+ Conversations
- Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
- Exclusive industry events
- Premium access to subscriber-only networking events around the country
- The best reporters in the industry
- The most trusted and well-connected newsroom in the health care industry
- And much more
- Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
Hola Diana,
Your article is interesting. But it seems as missing the fact that the trainees are producing. They are a workforce which in many cases is underpaid. Fresh brains. Full of ahas. I have seen this up close more than once.
Best,
Omar